Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Sight Sciences, Inc. SGHT
$9.97
-$0.01 (-0.15%)
На 18:04, 12 мая 2023
+50.45%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
489367220.00000000
-
week52high
15.30
-
week52low
5.35
-
Revenue
71331000
-
P/E TTM
-6
-
Beta
0.00000000
-
EPS
-1.97000000
-
Last Dividend
0.00000000
-
Next Earnings Date
13 мар 2023 г. в 20:30
Описание компании
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Piper Sandler | Overweight | Overweight | 12 авг 2022 г. |
| Morgan Stanley | Overweight | Overweight | 12 авг 2022 г. |
| Stifel | Hold | 26 июл 2022 г. | |
| Morgan Stanley | Overweight | Overweight | 15 июл 2022 г. |
| Piper Sandler | Overweight | Overweight | 11 мая 2022 г. |
| Needham | Hold | 04 окт 2022 г. | |
| Morgan Stanley | Overweight | Overweight | 11 окт 2022 г. |
| Morgan Stanley | Overweight | Overweight | 11 ноя 2022 г. |
| Stifel | Buy | Hold | 06 янв 2023 г. |
| Morgan Stanley | Overweight | Overweight | 06 янв 2023 г. |
| Citigroup | Buy | Buy | 12 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Fountain Tamara | A | 0 | 17977 | 08 янв 2023 г. |
| HAYDEN JEREMY B. | D | 1808 | 1192 | 04 янв 2023 г. |
| Badawi Paul | D | 5278481 | 8251 | 04 янв 2023 г. |
| Park Sam Boong | D | 51424 | 2393 | 04 янв 2023 г. |
| Badawi David | D | 1485790 | 2431 | 04 янв 2023 г. |
| Selnick Jesse | D | 403359 | 2891 | 04 янв 2023 г. |
| HAYDEN JEREMY B. | A | 3000 | 12000 | 01 янв 2023 г. |
| Badawi Paul | A | 5286732 | 87800 | 01 янв 2023 г. |
| Park Sam Boong | A | 53817 | 24100 | 01 янв 2023 г. |
| Badawi David | A | 1488221 | 28100 | 01 янв 2023 г. |
Новостная лента
Sight Sciences to Present at the Upcoming Piper Sandler 34th Annual Healthcare Conference
GlobeNewsWire
22 ноя 2022 г. в 08:30
MENLO PARK, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients' lives, today announced plans to participate in the upcoming Piper Sandler 34th Annual Healthcare Conference in New York, NY.
Sight Sciences, Inc. (SGHT) Q3 2022 Earnings Call Transcript
Seeking Alpha
13 ноя 2022 г. в 04:34
Sight Sciences, Inc. (NASDAQ:SGHT ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Philip Taylor - Investor Relations, Gilmartin Group Paul Badawi - Chief Executive Officer Jesse Selnick - Chief Financial Officer Conference Call Participants Cecilia Furlong - Morgan Stanley David Saxon - Needham & company Thomas Stephan - Stifel Financial Corp. Craig Bijou - Bank of America Securities, Inc. Operator Good day, and thank you for standing by. Welcome to the Sight Sciences Third Quarter 2022 Earnings Results Conference Call.
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research
10 ноя 2022 г. в 18:48
Sight Sciences, Inc. (SGHT) delivered earnings and revenue surprises of 2.13% and 5.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022
GlobeNewsWire
20 окт 2022 г. в 17:20
MENLO PARK, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients' lives, today announced it will report financial results for the third quarter ended September 30, 2022, after the market close on Thursday, November 10, 2022. The company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
GlobeNewsWire
02 сент 2022 г. в 08:00
MENLO PARK, Calif., Sept. 02, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients' lives, today announced plans to participate in the upcoming Morgan Stanley Global Healthcare Conference in New York, NY.